Latest Biologic Stories
NEW YORK, May 22, 2015 /PRNewswire/ -- The U.S.
Following Approval of the First Biosimilar in the U.S., Physician Groups Urge FDA to Give Full Consideration to Inclusion of Critical Information Needed by Physicians WASHINGTON, May 21, 2015
DUBLIN, May 20, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/c48z9q/global)
WASHINGTON, May 20, 2015 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP) joined forces with the
Bioreactor 6Pack(TM) facility design provides innovative, flexible solutions to customers for phase III and commercial production SEATTLE and BERKELEY, Calif.
According to a recent report by iData Research, in 2014, the European breast reconstruction market experienced high single-digit growth and will continue to do so over the next few years.
SAN DIEGO, May 7, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc.
DUBLIN, May 07, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/xc7ll7/china_blood)
Company plans to add more than 30,000L of bioreactor capacity across its three sites COPENHAGEN, Denmark, SEATTLE and BERKELEY, Calif., May 7, 2015 /PRNewswire/ --
-- Appointment Reflects Company's Expanded Clinical and Market Driven Focus -- ROCKVILLE, Md., May 7, 2015 /PRNewswire/ --
- To say in too many words; to express verbosely.
- To express in too many words: sometimes used reflexively.
- The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.